Konstantin Voropaev on patent law

Our colleague Konstantin Voropaev published an article in IPKat, Europe’s leading intellectual property blog with over 92 million views throughout its 22-year history. Below is a brief summary of his key insights:

“In 2024, courts in both America and Europe changed how they decide if inventions deserve patents. Two important cases – one about medicine in America (Janssen v. Teva) and another about gene technology in Europe (10x Genomics) – showed that courts now look at all previous technologies together, not separately. Before, they checked each old technology one by one, but now they understand that most new inventions combine many existing ideas. This new approach is more like how real inventors work and matches how the European Patent Office already handles patents. The courts now better understand the difference between truly new ideas that deserve patents and simple combinations of old ideas that don’t.”